Targeted hepatitis B vaccination - A cost effective immunisation strategy for the UK?

Journal of Epidemiology and Community Health

Volumn 50, Issue 6, 1996, Pages 667-673

  Williams, John R ^a   James Nokes, D ^b   Anderson, Roy M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEPATITIS B; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; IMMUNIZATION; MATHEMATICAL MODEL; SEXUAL TRANSMISSION; UNITED KINGDOM; VERTICAL TRANSMISSION;

EID: 0030462396     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.50.6.667     Document Type: Article

References (24)

1. Ghendon Y. WHO strategy for the global elimination of new cases of hepatitis B. Vaccine 1990;8(Suppl 1):S129-S33.
2. Roure C. Overview of epidemiology and disease burden of hepatitis B in the European region. Vaccine 1990;8(Suppl 1):S18-S21:
3. Kattamis C, Papaevangelou G. Workshop group: Greece. Vaccine 1990;8(Suppl 1):S97-S8.
4. Jilg W. Selective risk group strategies in Europe. Vaccine 1990;8(Suppl 1):S44-S6
5. Roure C. Congress objectives. Vaccine 1990;8(Suppl 1): S9-S10.
6. Kane M. Global programme for control of hepatitis B infection. Vaccine 1990;8(Suppl 1):S47-S9.
7. Mangtani P, Hall AJ, Normand CEM. Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales. J Epidemiol Community Health 1995;49:238-44.
8. Williams JR, Nokes DJ, Medley GF, Anderson RM. The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunisation programmes. Epidemiol Infect 1996;116(1):71-89.
9. El-Dalil A, Radcliffe KW, Bailey J, Richmond RA, Wade AAH. A survey on hepatitis B vaccination policies in genitourinary medicine in UK and Ireland. Genitourin Med 1995;71:251-3.
10. Bhatti N, Gilson RJC, Beecham M, Williams P, Matthews MP, Tedder RS, Weller IVD. Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ 1991;303:97-101.
11. Fine PEM. Herd immunity: history, theory and practice. Epidemiol Rev 1993;15(2):265-302.
12. Johnson AM, Wadsworth J, Wellings K, Field J, Bradshaw S. Sexual attitudes and lifestyles. Oxford: Blackwell Scientific Publications, 1994.
13. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press, 1991.
14. André FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990;8(Supp): S74-S8.
15. Laukamm-Josteb U, von Laer G, Feldmeier H, Bienzle U, Uy A, Thomssen R, Guggenmoos-Holzmann I. Active immunization against hepatitis B: Immunogenicity of a recombinant DNA vaccine in females, heterosexual and homosexual males. Postgrad Med J 1987;63(Supp2):143-46.
16. Wheeley SM, Tarlow MJ, Boxall EH. Chronic hepatitis B in male and female children of HBsAg carrier mothers J Hepatol 1989;8:226-31.
17. Brook MG, Lever AML, Kelly D, Rutter D, Trompeter RS, Griffiths P, Thomas HC. Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. QJM 1989;71:313-17.
18. Derso A, Boxall EH, Tarlow MJ, Flewett TH. Transmission of HBsAg from mother to infant in four ethnic groups. BMJ 1978,1:949-52.
19. Nandwani R, Barton S. Medical audit of hepatitis B immunization policy in a genitourinary medicine clinic. Int J STD AIDS 1993;4:244.
20. Sherlock S. Hepatitis B: the disease. Vaccine 1990,8(Suppl 1):S6-S9.
21. Clee WB, Hunter PR. Hepatitis B virus in general practice: Epidemiology, clinical and serological features, and control. BMJ 1987;295:530-2.
22. Williams JR, Nokes DJ, Anderson RM. Assessment of the impact of various strategies to control hepatitis B infection. In: Zuckerman A ed. The prevention of hepatitis B in the newborn, children and adolescents. In press.
23. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. International Statistical Review 1994;62(2):229-43.
24. Kane M. Epidemiology of hepatitis B infection in North America. Vaccine 1990;8(Suppl 1):S16-S17.